President Signs Opioid Legislation into Law
Today, President Trump signed the SUPPORT for Patients and Communities Act into law to further address the nation’s ongoing opioid crisis.
According to the Centers for Disease Control and Prevention (CDC), more than 49,000 people died from opioid overdose in 2017. The bill, which passed out of Congress with bipartisan support, is aimed to help combat the epidemic in several ways.
The bill increases access to treatment and recovery services, enhances prescription drug monitoring programs, and limits illegal shipments of fentanyl and other synthetic opioids by requiring the U.S. Postal Service to obtain electronic data on international mail shipments that can be used to target packages for inspection.
In addition, the bill expands access to substance abuse treatment in Medicaid. Practitioners and other providers can also begin to prescribe buprenorphine to treat victims of opioid addiction.
NCPA has put together a fact sheet explaining some of the aspects of the bill and how they pertain to independent pharmacies.
“Together we are going to end the scourge of drug addiction in America,” said Trump during a signing ceremony at the White House. “We are either going to end it or we are going to make an extremely big dent in this terrible, terrible problem.”